This company has been marked as potentially delisted and may not be actively trading. AveXis (AVXS) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock AVXS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Novartis ‘focusing on high-end, innovative medicines,’ CEO saysMay 24, 2023 | finance.yahoo.comIonis Childhood Spine Disorder Drug Notches Pivotal Study Win, Triggers Biogen OptionJanuary 2, 2023 | thestreet.comGoogle-backed gene therapy firm launches Morrisville manufacturing facility - The Business JournalsSeptember 21, 2022 | bizjournals.comRegenxbio Stock: A Transformative Year (NASDAQ:RGNX) - Seeking AlphaSeptember 15, 2022 | seekingalpha.comGenSight Biologics Strengthens Its Management Team to Support the Launch of LUMEVOQ® in Europe - Yahoo FinanceSeptember 12, 2022 | finance.yahoo.comREGENXBIO: Gene Therapy Pioneer Moving To Late-Stage Development (NASDAQ:RGNX) - Seeking AlphaAugust 29, 2022 | seekingalpha.comOnce high-flying Dallas biotech sees promising drug data amid growing financial pressure - The Dallas Morning NewsAugust 29, 2022 | dallasnews.comDIt's in our DNA: Why the Columbus Region is a hub for gene therapy companies - Columbus Business First - The Business JournalsAugust 20, 2022 | bizjournals.comRelief Therapeutics Appoints David McCullough as Head of U.S. Market Access - StreetInsider.comAugust 17, 2022 | streetinsider.comPopular Open Source GraphQL Company Dgraph Secures $6M in Seed Round with New Leadership - PR NewswireJuly 20, 2022 | prnewswire.comGeneration Bio Appoints Dannielle Appelhans to Its Board of Directors - GlobeNewswireJuly 18, 2022 | globenewswire.comGlobal Cell and Gene Therapy Market Analysis/Opportunities Report 2022-2035: Niche Startups are Spearheading the Innovation in this Domain - Yahoo FinanceJune 9, 2022 | finance.yahoo.comGlobal Cell and Gene Therapy Market Analysis/Opportunities Report 2022-2035: Niche Startups are Spearheading the Innovation in this Domain - PR NewswireJune 9, 2022 | prnewswire.comGlobal Cell and Gene Therapy Market Investor/Opportunities Report 2022: Evaluate the Current/Future Potential Over the Coming Decades - GlobeNewswireJune 8, 2022 | globenewswire.comBLUE stock drives gene therapy stocks higher after FDA review (NASDAQ:BLUE) - Seeking AlphaJune 7, 2022 | seekingalpha.comSumo Logic Appoints John D. Harkey, Jr. to Board of Directors - Yahoo FinanceMay 3, 2022 | finance.yahoo.comSatellite Bio Reveals Pioneering Tissue Therapeutics, Bioengineered Tissues That Restore Organ Function, Bringing Hope Across Diseases - StreetInsider.comApril 21, 2022 | streetinsider.comRegenxbio: Is The Ultimate Catalyst Coming? - Seeking AlphaApril 20, 2022 | seekingalpha.comSatellite Bio Reveals Pioneering Tissue Therapeutics, Bioengineered Tissues That Restore Organ Function, Bringing Hope Across Diseases - Business WireApril 20, 2022 | businesswire.comSamsung invests in Chicago biotech Jaguar Gene Therapy - The Business JournalsMarch 29, 2022 | bizjournals.comNkarta Appoints Manufacturing Technology Executive, Angela Thedinga, to Board of Directors - Yahoo FinanceMarch 29, 2022 | finance.yahoo.comTScan Therapeutics Reports Full Year 2021 Financial Results and Highlights Key 2022 Priorities - Yahoo FinanceMarch 9, 2022 | finance.yahoo.comTaysha Gene Therapies Gets A 'Thumbs Up' - Seeking AlphaMarch 7, 2022 | seekingalpha.com'It's a real-life Hunger Games': a lifesaving drug costs $2m, but not every child can get it - The GuardianMarch 5, 2022 | theguardian.comNEW STATE AVIATION HOLDINGS NAMES CEO AND CFO - PRNewswireFebruary 14, 2022 | prnewswire.comIxaka Expands Management Team with Multiple Appointments - StreetInsider.comFebruary 11, 2022 | streetinsider.comGlobal Cell & Gene Therapy Market Research Report 2022: Expanding Application for Cell & Gene Therapies & Growing Demand for CAR T- Cell Therapies - Yahoo FinanceFebruary 2, 2022 | finance.yahoo.comGenSight Biologics Appoints Sissel Rodahl as Senior Vice-President of Commercial Operations to Lead the Launch of LUMEVOQ® in Europe - Business WireFebruary 2, 2022 | businesswire.comGenSight Biologics Appoints Sissel Rodahl as Senior Vice-President of Commercial Operations to Lead the Launch of LUMEVOQ® in Europe - StreetInsider.comFebruary 1, 2022 | streetinsider.comWhy I'm Staying Away From Affinia Therapeutics' IPO For Now - Seeking AlphaJanuary 19, 2022 | seekingalpha.comNEW STATE CAPITAL ACQUIRES AVEX - PRNewswireDecember 21, 2021 | prnewswire.comGlobal Cell Gene Therapy Clinical Trials Report 2028 - Benzinga - BenzingaDecember 17, 2021 | benzinga.comBrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs - Yahoo FinanceNovember 9, 2021 | finance.yahoo.comBrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs - PRNewswireNovember 8, 2021 | prnewswire.comGene Therapy Is a Huge Opportunity. It Pays to be Patient. - Barron'sNovember 5, 2021 | barrons.comTesting May Take Awhile, but Gene Therapy Is Poised to Tackle Mass Diseases - Barron'sNovember 5, 2021 | barrons.com$14,996.35Mn by 2028 Healthcare Regulatory Affairs - GlobeNewswireNovember 2, 2021 | globenewswire.comWhat Jaguar Gene Therapy plans for $125M expansion in Research Triangle Park - Triangle Business JournalOctober 30, 2021 | bizjournals.comX4 Pharmaceuticals Expands Commercial Leadership Expertise with Appointment of Françoise de Craecker to Board of Directors and Karolyn Park as Vice President, U.S. Commercial - Yahoo FinanceOctober 19, 2021 | finance.yahoo.comDelix Therapeutics Named One of Fierce Biotech's "Fierce 15" Companies of 2021 - Yahoo FinanceOctober 5, 2021 | finance.yahoo.comDelix Therapeutics Named One of Fierce Biotech's "Fierce 15" Companies of 2021 - PRNewswireOctober 4, 2021 | prnewswire.comGlobal $21.2 Bn Advanced Therapy Medicinal Products Market to 2028: Breakthrough Approvals of Tecartus and Abecma Post-approval of Zolgensma, Kymriah, and Yescarta have Bolstered Rapid Advancements - Yahoo FinanceSeptember 23, 2021 | finance.yahoo.comGlobal Advanced Therapy Medicinal Products (ATMPs) Market to 2028: Focus on CAR-T, Gene, Cell, Stem Cell Therapy - ResearchAndMarkets.com - Yahoo FinanceSeptember 22, 2021 | finance.yahoo.comCoinFund : Appoints Top Venture Capitalist David Pakman as Managing Partner - marketscreener.comSeptember 22, 2021 | marketscreener.comM5 Gene Therapy Stocks Back in Focus on AbbVie/Regenxbio Deal - Yahoo FinanceSeptember 14, 2021 | finance.yahoo.comRegenxBio, AbbVie sign commercialization deal for Rockville company's eye disease treatment - Washington Business Journal - Washington Business JournalSeptember 13, 2021 | bizjournals.comDallas biotech company wins $14.4 million grant from Texas’ cancer research fund - The Dallas Morning NewsAugust 20, 2021 | dallasnews.comDAGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site - StreetInsider.comAugust 9, 2021 | streetinsider.com Get AveXis News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXS and its competitors with MarketBeat's FREE daily newsletter. Email Address AVXS Media Mentions By Week AVXS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVXS News Sentiment▼0.000.57▲Average Medical News Sentiment AVXS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVXS Articles This Week▼00▲AVXS Articles Average Week Get AveXis News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Prime Medicine News Inhibikase Therapeutics News Protalix BioTherapeutics News Invizyne Technologies News ZIVO Bioscience News Calidi Biotherapeutics News AlloVir News NKGen Biotech News CEL-SCI News Chromocell Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVXS) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AveXis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AveXis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVXS Stock Alerts